Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L. Reuteri + Vit. D3 in Asthmatic Children
NCT02734446Phase 3Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Apr 2014
- Primary completion
- Feb 2015
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma (2 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoints: Fractional exhaled nitric oxide at 3 months and Bronchial inflammation markers (IL-2, IL-4, IL-10, IFN-gamma) at 3 months. Started Apr 2014; status: completed.
02
Conditions
asthma
Beyond the preview
Go deeper on NCT02734446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734446.